Concepedia

Shibadas Biswal

SB

14

Publications

1.4K

Citations

12

H-Index

2006

Active since

Affiliations

Takeda (Switzerland)(Current)

Research Institute for Tropical Medicine

Takeda (United States)

Universidad del Valle

Hospital del Niño

Shibadas Biswal is an author at Takeda (Switzerland) specializing in vaccination, vaccine safety, and medicine.

ORCID

Top concepts

Publications per year

2006–2024

14

Publications

14

Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents

Shibadas Biswal, Humberto Reynales, Xavier Sáez‐Llorens et al. · New England Journal of Medicine · 2019 · 357 citations · Full text

Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial

Shibadas Biswal, Charissa Borja-Tabora, Luis Martinez Vargas et al. · The Lancet · 2020 · 237 citations

, , +5

Three-year Efficacy and Safety of Takeda’s Dengue Vaccine Candidate (TAK-003)

Luis Rivera, Shibadas Biswal, Xavier Sáez‐Llorens et al. · Clinical Infectious Diseases · 2021 · 226 citations · Full text

Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial

Vianney Tricou, Delia Yu, Humberto Reynales et al. · The Lancet Global Health · 2024 · 189 citations · Full text

Everolimus for the treatment of lymphangioleiomyomatosis: a phase II study

Hilary J. Goldberg, Sergio Harari, Vincent Cottin et al. · European Respiratory Journal · 2015 · 103 citations · Full text

Rows per page

1–5 of 14